Covered recipient · General Payments record
TINGTING ZHOU
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$506.35
- Reported across 23 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.63 | 11 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $54.93 | 3 |
| ABBVIE INC. | $36.54 | 2 |
| Lilly USA, LLC | $28.79 | 1 |
| PFIZER INC. | $24.95 | 1 |
| Acerta Pharma LLC | $23.92 | 1 |
| Amgen Inc. | $20.12 | 1 |
| GlaxoSmithKline, LLC. | $19.72 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.85 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204861426 | CMS |
| ABBVIE INC. | $15.69 | 12/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204861430 | CMS |
| Amgen Inc. | $20.12 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228430858 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.92 | 12/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206647999 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.66 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222740803 | CMS |
| GlaxoSmithKline, LLC. | $19.72 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190716051 | CMS |
| Lilly USA, LLC | $28.79 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186870035 | CMS |
| Novo Nordisk Inc | $18.58 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188260057 | CMS |
| Novo Nordisk Inc | $19.53 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188872113 | CMS |
| Novo Nordisk Inc | $16.82 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188430077 | CMS |
| PFIZER INC. | $24.95 | 10/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230648202 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.